Home   >    COVID-19   >   Covid-19 Proteins

2019-nCoV Spike protein S1 (L452R, E484Q, D614G, P681R)

Recombinant 2019-nCoV Spike protein S1(16-685) with L452R, E484Q, D614G, and P681R was expressed in CHO cells using a C-terminal His- tag. The gene accession number is MN908947.
Catalog No. C19S1-G231EH




Catalog No. Pack Size Price (USD)
C19S1-G231EH-10 10 ug $100
C19S1-G231EH-20 20 ug $190
C19S1-G231EH-50 50 ug $290
C19S1-G231EH-100 100 ug $435
C19S1-G231EH-BULK BULK Contact Us  


Genbank Number:


References:

1. Zhou P, et al: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020, 579:270-89.

2. Lan J, et al: Crystal structure of the 2019-nCov spike receptor-binding domain bound with the ACE2 receptor. Nature. 2020, 581:215-220.

3. Takuya T, et al: The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies. 2021. doi: https://doi.org/10.1101/2021.05.14.444076


Specific Activity:

Sample activity data. For lot specific data, please refer to the respective datasheet.


Purity:

Sample purity data. For lot specific data, please refer to the respective datasheet.


Alternative name(s):

2019-nCoV s1, SARS-CoV-2 spike S1, SARS-CoV-2 S1, novel coronavirus spike s1, nCov spike s1, coronavirus spike S1. The UniProt accession number is P0DTC2.


Storage and Stability:

Aliquot product into smaller quantities after centrifugation and store at –70oC. For best performance, avoid repeated handling and multiple freeze/thaw cycles.


Scientific Background :

Novel coronavirus SARS-CoV-2 has caused the pandemic of respiratory diseases (COVID-19) around the world since 2020 (1). The spike glycoprotein (S) of coronavirus, a type I transmembrane protein containing two subunits, S1 and S2 is known to bind with host cells through the interaction with angiotensin-converting enzyme 2 (ACE2) and facilitate viral entry into the host cell (2). The highly transmissible B.1.617 variant identified in India has mutations (L452R, E484Q, D614G, P681R) in the spike protein. These mutations may result in increased transmissibility and re-infection or resistance to vaccine-elicited antibody. As new variants emerge, it is pivotal to evaluate their transmissibility, virulence, and their possible tendency to escape antibody neutralization (3).


Molecular Weight:

approx. MW ~120 kDa calc. MW 76.4 kDa



Product Datasheets



There are no related publications available for this product.


RESEARCH AREAS

COVID19



SIGNALCHEM BIOTECH INC.


About

Terms of Service

Privacy Policy

Get the latest resources, updates and offers in your inbox